Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatment

BACKGROUND: A certain proportion of non-small cell lung cancer (NSCLC) with activating EGFR mutations showed resistance to tyrosine kinase inhibitors (TKIs) by transforming their histology into small cell lung cancer (SCLC). In this study, we evaluated the molecular characteristics of transformed SC...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Soohyun, Hong, Tae Hee, Park, Sehhoon, Jung, Hyun-Ae, Sun, Jong-Mu, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Choi, Yoon-La, Lee, Se-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674595/
https://www.ncbi.nlm.nih.gov/pubmed/35004251
http://dx.doi.org/10.21037/tlcr-21-691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674595/
https://www.ncbi.nlm.nih.gov/pubmed/35004251
http://dx.doi.org/10.21037/tlcr-21-691

Ejemplares similares